Mood disorders CPG and associated resources

The 2020 guideline builds on the previous 2015 Clinical Practice Guideline and maintains its joint focus on both depressive and bipolar disorders.

Access further guidance on specific treatments for mood disorders in the following documents developed by the College:

• Electroconvulsive therapy (ECT)
• Repetitive transcranial magnetic stimulation (rTMS)
• Transcranial direct current stimulation (tDCS)
• Ketamine therapy
• Medicinal cannabis 
• Psychotherapy conducted by psychiatrists.

Key practice points

The 2020 guideline builds on the previous guidelines (issued in 2015) and provides up-to-date recommendations and guidance within an evidence-based framework, supplemented by expert clinical consensus. 

The 2020 guideline: 

• discusses the diagnosis and management of both depressive and bipolar disorders, recognising that these have increasingly been conceptualised as part of a spectrum
• illustrates step-by-step the clinical management of mood disorders
• provides guidance on the management of psychiatric comorbidities, including comorbid anxiety and comorbid substance use
• considers the clinical management of mood disorders with complex presentations and in special populations. 

Webinar recordings and e-learning modules

Delivered via the RANZCP's e-learning platform, Learnit.  Member sign-in is required to access the modules.

• Innovations in the 2020 RANZCP Clinical Practice Guideline for Mood Disorders 
• Black and blue: bipolar II 
• Electroconvulsive therapy
• Side-effects of antipsychotics

Podcasts

New Clinical Guidelines for Mood Disorders: Management of Major Depressive Disorder and Treatment Non-Response

New Clinical Guidelines for Mood Disorders: Classification, Diagnosis, Assessment and Formulation

Community resources

• Information for the public about bipolar disorder
• Information for the public about depression